Next Article in Journal
Novel Genetic Variants Explaining Severe Adverse Drug Events after Clinical Implementation of DPYD Genotype-Guided Therapy with Fluoropyrimidines: An Observational Study
Previous Article in Journal
Glioma-Associated Sialoglycans Drive the Immune Suppressive Phenotype and Function of Myeloid Cells
Previous Article in Special Issue
Tailoring Treatment in Cardiovascular Diseases: The Role of Targeted Therapies
 
 
Article

Article Versions Notes

Pharmaceutics 2024, 16(7), 955; https://doi.org/10.3390/pharmaceutics16070955
Action Date Notes Link
article xml file uploaded 19 July 2024 06:24 CEST Original file -
article xml uploaded. 19 July 2024 06:24 CEST Update https://www.mdpi.com/1999-4923/16/7/955/xml
article pdf uploaded. 19 July 2024 06:24 CEST Version of Record https://www.mdpi.com/1999-4923/16/7/955/pdf
article supplementary file uploaded. 19 July 2024 06:24 CEST - https://www.mdpi.com/1999-4923/16/7/955#supplementary
article html file updated 19 July 2024 06:27 CEST Original file https://www.mdpi.com/1999-4923/16/7/955/html
Back to TopTop